What are the limitations of the mrd assessment threshold interpreter?

While the mrd assessment threshold interpreter is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the mrd assessment threshold interpreter to ensure safe bedside use and optimal diagnostic accuracy.

How does the mrd assessment threshold interpreter compare to other Hematology scores?

The mrd assessment threshold interpreter is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the mrd assessment threshold interpreter free to use?

Yes. OpiCalc provides the mrd assessment threshold interpreter completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

MRD Assessment Threshold Interpreter

MRD Sensitivity: Assessing the "depth" of clinical remission. NGS (10⁻⁶) is significantly more sensitive than standard flow.

Sensitivity Threshold

1 in 100,000 cells

Enabled by: Next-Gen Flow (NGF)

Clinical Use Case

Current NCCN/EHA minimum for MRD-negativity in trials.

Comparison

100x more sensitive than standard flow.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Interpreting Minimal Residual Disease (MRD) results in patients with Multiple Myeloma, CLL, or AML.

Evaluating the sensitivity of the assay (Flow vs. NGS).

Applying IMWG or ELN definitions for MRD negativity.

Patient Population

Patients in clinical remission (e.g., CR or sCR) who are being assessed for deeper molecular or cellular responses.

Section 2

Formula & Logic

Sensitivity Levels

Threshold	Meaning (1 in X cells)	Standard Method
10⁻⁴	1 in 10,000	Standard multi-parameter flow
10⁻⁵	1 in 100,000	NGF (Next Gen Flow) / NCCN Minimum
10⁻⁶	1 in 1,000,000	NGS (Next Gen Sequencing) / IMWG standard

IMWG MRD Definitions

MRD Negativity: Absence of clonal plasma cells by NGF or NGS at a minimum sensitivity of 1 in 10⁵.

Sustained MRD Negativity: MRD negativity confirmed ≥ 1 year apart.

Imaging MRD-Negative: Complete metabolic response (PET/CT) in addition to cellular MRD negativity.

Section 3

Pearls/Pitfalls

Flow vs. NGS

Next-Generation Flow (NGF) provides rapid results (hours) but depends on fresh samples. Next-Generation Sequencing (NGS) offers higher sensitivity (10⁻⁶) and can use stored samples, but requires a baseline tracking sample (the "molecular signature").

Prognostic Power

In Multiple Myeloma, achieving MRD negativity is a more powerful predictor of survival than achieving a clinical CR. It is increasingly used as a surrogate endpoint for drug approval.

Section 4

Evidence Appraisal

Primary Consensus

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

Kumar S et al. • Lancet Oncology. 2016;17(8):e328-e346.

View Source

Next-generation flow cytometry for highly sensitive and standardized detection of MRD in multiple myeloma.

Paiva B et al. • Leukemia. 2016;30(10):2103-6.

View Source

Section 5

Literature

Terminology

The term "Minimal Residual Disease" is increasingly being replaced by "Measurable Residual Disease" to reflect improved detection capabilities.

Last Comprehensive Review: 2026

Related Hematology Tools

IPSID / Lugano Classification

Deauville Score Interpreter

CLL-IPI

Binet / Rai Staging

iwCLL Response Criteria

Revised Response Criteria

PCNSL MSKCC Score

ISS

R-ISS

IMWG Response Criteria

Have feedback about this calculator?Let us know.